Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124915194 | 12491519 | 4 | F | 20160607 | 20160803 | 20160623 | 20160817 | EXP | PHEH2016US014937 | SANDOZ | 84.88 | YR | M | Y | 89.00000 | KG | 20160817 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124915194 | 12491519 | 1 | SS | ENTRESTO | SACUBITRILVALSARTAN | 1 | Oral | 200 (97/103 MG) UNK, BID | 62000 | MG | 0 | 200 | MG | BID | |||||
| 124915194 | 12491519 | 2 | SS | ENTRESTO | SACUBITRILVALSARTAN | 1 | Oral | 50 (24/26 MG) UNK, BID | 62000 | MG | 0 | 50 | MG | BID | |||||
| 124915194 | 12491519 | 3 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, QD | U | 18569 | 40 | MG | QD | ||||||
| 124915194 | 12491519 | 4 | SS | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0.4 MG, QD | U | 0 | .4 | MG | QD | ||||||
| 124915194 | 12491519 | 5 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 124915194 | 12491519 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 124915194 | 12491519 | 7 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 81 MG, QD | U | 0 | 81 | MG | QD | ||||||
| 124915194 | 12491519 | 8 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 3.125 MG, BID | U | 0 | 3.125 | MG | BID | ||||||
| 124915194 | 12491519 | 9 | C | CARVEDILOL. | CARVEDILOL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124915194 | 12491519 | 1 | Cardiac failure congestive |
| 124915194 | 12491519 | 3 | Cardiac failure congestive |
| 124915194 | 12491519 | 4 | Benign prostatic hyperplasia |
| 124915194 | 12491519 | 5 | Hyperlipidaemia |
| 124915194 | 12491519 | 6 | Gastrooesophageal reflux disease |
| 124915194 | 12491519 | 7 | Arteriosclerosis coronary artery |
| 124915194 | 12491519 | 8 | Cardiac failure congestive |
| 124915194 | 12491519 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124915194 | 12491519 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124915194 | 12491519 | Face injury | |
| 124915194 | 12491519 | Facial bones fracture | |
| 124915194 | 12491519 | Fall | |
| 124915194 | 12491519 | Haemorrhage | |
| 124915194 | 12491519 | Hypotension | |
| 124915194 | 12491519 | Loss of consciousness | |
| 124915194 | 12491519 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124915194 | 12491519 | 1 | 20160105 | 20160607 | 0 | |
| 124915194 | 12491519 | 3 | 20150831 | 0 | ||
| 124915194 | 12491519 | 4 | 20160111 | 0 | ||
| 124915194 | 12491519 | 5 | 20150201 | 0 | ||
| 124915194 | 12491519 | 6 | 20120419 | 0 | ||
| 124915194 | 12491519 | 7 | 20120101 | 0 | ||
| 124915194 | 12491519 | 8 | 20140408 | 0 |